...
首页> 外文期刊>The American Journal of Cardiology >Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute st-segment elevation myocardial infarction
【24h】

Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute st-segment elevation myocardial infarction

机译:血小板/淋巴细胞比在预测急性st段抬高型心肌梗死患者初次经皮冠状动脉介入治疗后预测血管造影回流中的作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Impaired coronary flow after primary percutaneous coronary intervention (PPCI) is associated with short- and long-term morbidity and mortality in patients with acute ST-segment elevation myocardial infarction (STEMI). Recent studies have demonstrated that platelet-to-lymphocyte ratio (PLR) is associated with adverse cardiovascular outcomes. The aim of this study was to assess the relation between admission PLR and angiographic reflow after PPCI. A total of 520 patients with acute STEMI (age 60 ± 13 years; 74% men) occurring within 12 hours of the onset of symptoms who underwent PPCI were enrolled. The PLR and other laboratory parameters were measured before PPCI. The patients were divided into 2 groups based on the postintervention Thrombolysis in Myocardial Infarction (TIMI) flow grade: normal-reflow group (defined as postintervention TIMI grade 3 flow) and none-reflow group (consisted of both patients with angiographic no-reflow defined as postintervention TIMI grades 0 to 1 flow and slow flow defined as postintervention TIMI grade 2 flow). There were 117 patients (22.5%) in the none-reflow group (age 68 ± 13 years and 77% men) and 403 patients in the normal-reflow group (age 58 ± 12 years and 63% men). The none-reflow group had significantly higher PLR compared with the normal-reflow group (219 ± 79 vs 115 ± 59, p <0.001). In logistic regression analysis, PLR (odds ratio 1.818, 95% confidence interval 1.713 to 1.980, p <0.001) and total stent length (OR 1.052, confidence interval 1.019 to 1.086, p = 0.002) were independent predictors of none-reflow after PPCI. In conclusion, preintervention PLR is a strong and independent predictor of slow flowo-reflow after PPCI in patients with acute STEMI.
机译:急性ST段抬高型心肌梗死(STEMI)患者初次经皮冠状动脉介入治疗(PPCI)后冠状动脉血流异常与短期和长期发病率及死亡率相关。最近的研究表明,血小板与淋巴细胞的比例(PLR)与不良的心血管预后相关。这项研究的目的是评估PPCI入院PLR和血管造影回流之间的关系。纳入入选PPCI症状发作后12小时内发生的520例急性STEMI患者(年龄60±13岁;男性占74%)。在PPCI之前测量PLR和其他实验室参数。根据干预后的心肌梗塞(TIMI)血流分级将患者分为2组:正常再流组(定义为干预后TIMI 3级血流)和无再流组(均由定义为无血管造影的两名患者组成)干预后TIMI为0到1级,慢流定义为干预后TIMI 2级。无复流组有117例患者(22.5%)(68±13岁,男性占77%),正常复流组有403例患者(58±12岁,男性63%)。与正常回流组相比,无回流组的PLR明显更高(219±79对115±59,p <0.001)。在逻辑回归分析中,PLR(赔率1.818,95%置信区间1.713至1.980,p <0.001)和支架总长度(OR 1.052,置信区间1.019至1.086,p = 0.002)是PPCI后无复流的独立预测因子。 。总之,在急性STEMI患者中,干预前PLR是PPCI后缓慢流/无复流的有力且独立的指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号